MENU
+Compare
GNLX
Stock ticker: NASDAQ
AS OF
Feb 28 closing price
Price
$4.18
Change
-$0.13 (-3.02%)
Capitalization
144.37M

GNLX Genelux Corp Forecast, Technical & Fundamental Analysis

Genelux Corp is a clinical-stage biopharmaceutical company... Show more

GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for GNLX with price predictions
Feb 28, 2025

Aroon Indicator for GNLX shows an upward move is likely

GNLX's Aroon Indicator triggered a bullish signal on February 24, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 42 similar instances where the Aroon Indicator showed a similar pattern. In of the 42 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where GNLX advanced for three days, in of 116 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for GNLX moved out of overbought territory on February 18, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 7 similar instances where the indicator moved out of overbought territory. In of the 7 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on February 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GNLX as a result. In of 34 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for GNLX turned negative on February 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 16 similar instances when the indicator turned negative. In of the 16 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GNLX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GNLX broke above its upper Bollinger Band on February 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GNLX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.363) is normal, around the industry mean (11.857). P/E Ratio (0.000) is within average values for comparable stocks, (80.120). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.578). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. GNLX's P/S Ratio (10000.000) is very high in comparison to the industry average of (242.214).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GNLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

GNLX is expected to report earnings to rise 31.58% to -25 cents per share on April 07

Genelux Corp GNLX Stock Earnings Reports
Q4'24
Est.
$-0.25
Q3'24
Beat
by $0.06
Q2'24
Beat
by $0.02
Q1'24
Missed
by $0.06
Q4'23
Missed
by $0.07
The last earnings report on November 14 showed earnings per share of -18 cents, beating the estimate of -25 cents. With 148.79K shares outstanding, the current market capitalization sits at 144.37M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2625 Townsgate Road
Phone
+1 805 267-9889
Employees
23
Web
https://www.genelux.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NFEAX16.710.31
+1.89%
Columbia Large Cap Growth Opp A
JHBCX60.351.11
+1.87%
JHancock Blue Chip Growth NAV
JFGAX10.290.16
+1.58%
JHancock Fundamental Global Fran A
LOGIX54.630.59
+1.09%
Scharf Institutional
RYHRX41.420.34
+0.83%
Rydex Real Estate H

GNLX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GNLX has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if GNLX jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNLX
1D Price
Change %
GNLX100%
-3.02%
VSTM - GNLX
47%
Loosely correlated
+3.04%
SNSE - GNLX
31%
Poorly correlated
+6.15%
ZLDAF - GNLX
26%
Poorly correlated
N/A
GNMSF - GNLX
26%
Poorly correlated
-0.86%
UNCY - GNLX
24%
Poorly correlated
-2.52%
More